'Sutureless' Surgical Aortic Valves Gain Medicare Bonus Payments
Edwards LifeScience’s Intuity Elite and LivaNova’s Perceval sutureless valves were granted a $6,000 new technology hospital inpatient add-on payment for fiscal 2018.
You may also be interested in...
A snapshot of global medical device and diagnostics approvals recorded during the past week in Medtech Insight's Approvals Tracker.
Starts & Stops is a regular feature highlighting Medtech Insight editors' picks of noteworthy medtech clinical trial announcements, initiations, completions, and suspensions each month. This month's edition, covering the period between mid-July and mid-August, includes trials from the biggest medtech players, some start-ups, and companies of every size in between.
July was a relatively light month for novel-device approvals by US FDA, but year-to-date volumes remain strong. Spotlighted devices include approval of a new drug-coated balloon and heart valve devices. Here's a roundup from Medtech Insight's Approval Tracker.